0001808352-22-000002.txt : 20221020 0001808352-22-000002.hdr.sgml : 20221020 20221020123209 ACCESSION NUMBER: 0001808352-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221020 DATE AS OF CHANGE: 20221020 EFFECTIVENESS DATE: 20221020 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PIC Therapeutics, Inc. CENTRAL INDEX KEY: 0001808352 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-462349 FILM NUMBER: 221320583 BUSINESS ADDRESS: STREET 1: 75 KNEELAND STREET, 14TH FLOOR CITY: BOSTON STATE: MA ZIP: 02111 BUSINESS PHONE: 617-637-3738 MAIL ADDRESS: STREET 1: 75 KNEELAND STREET, 14TH FLOOR CITY: BOSTON STATE: MA ZIP: 02111 D 1 primary_doc.xml X0708 D LIVE 0001808352 PIC Therapeutics, Inc. 22 Strathmore Road Suite 115 Natick MA MASSACHUSETTS 01760 617-528-8715 DELAWARE None None Corporation true Dr. Katherine S. Bowdish c/o PIC Therapeutics, Inc. 22 Strathmore Road, Suite 115 Natick MA MASSACHUSETTS 01760 Executive Officer Director Dr. Alan E. Walts c/o PIC Therapeutics, Inc. 22 Strathmore Road, Suite 115 Natick MA MASSACHUSETTS 01760 Director Dr. Gerhard Wagner c/o PIC Therapeutics, Inc. 22 Strathmore Road, Suite 115 Natick MA MASSACHUSETTS 01760 Director Belinda Termeer c/o PIC Therapeutics, Inc. 22 Strathmore Road, Suite 115 Natick MA MASSACHUSETTS 01760 Director Tal Zaks, MD, PhD c/o OrbiMed Advisors LLC General Counsel 601 Lexington Avenue, 54th Floor New York NY NEW YORK 10022 Director Gerry Brunk c/o Lumira Ventures 141 Adelaide Street West, Suite 770 Toronto A6 ONTARIO, CANADA M5H 3L5 Director Biotechnology Decline to Disclose 06b false 2022-10-07 true true false 0 35000000 6475472 28524528 false 22 0 0 0 true false PIC Therapeutics, Inc. /s/ Dr. Katherine Bowdish Katherine S. Bowdish, PhD President and Chief Executive Officer 2022-10-19